U.S. SECURITIES AND EXCHANGE
COMMISSION

WASHINGTON, D.C. 20549



FORM 10-Q



[X] QUARTERLY REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For the quarterly period ended: June
30, 2012



OR



[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934



For the transition period from ___ to ____



Commission File Number 000-31012



GLOBAL HEALTH VOYAGER, INC.

(Exact name of registrant as specified in its
charter)



|Delaware                                                       |  | 94-3357128                          
|-------------------------------------------------------------- |  | ------------------------------------
|(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
|                                                               |  |                                     
|7800 Oceanus Drive                                             |  |                                     
|Los
    Angeles, California                                    |  | 90046                               
|(Address of principal executive offices)                       |  | (Zip Code)                          



Registrants telephone number: (323) 445-4833



Indicate by check mark whether the registrant (1)
has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes [X]   No [  ]



Indicate by check mark
whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data
File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files).
 Yes [X]   No [  ]



Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions
of "large accelerated filer," ”accelerated filer”and “smaller reporting company” in Rule 12b-2
of the Exchange Act.



|Large accelerated filer [  ]                                              | Accelerated filer [  ]       
|------------------------------------------------------------------------- | -----------------------------
|Non-accelerated filer [  ]  (Do not check if a smaller reporting company) | Smaller reporting company [X]



Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act). Yes [  ]   No [X]



Number of shares
outstanding as of  August 20, 2012:45,820,431common shares.


















Form 10-Q

INDEX





|           |                       |                                                                                           | Page
    No.
|---------- | --------------------- | ----------------------------------------------------------------------------------------- | ------------
|PART I.    | Financial Information |                                                                                          
|           |                       |                                                                                          
|           | Item 1.               | Consolidated Financial Statements:                                                        | F-1         
|           |                       |                                                                                           |             
|           |                       | Notes to Consolidated Financial Statements                                                | F-4         
|           |                       |                                                                                           |             
|           | Item 2.               | Management’s Discussion and Analysis of Financial Condition
    and Results of Operations | 3           
|           |                       |                                                                                           |             
|           | Item 3.               | Quantitative and Qualitative Disclosures About Market Risk                                | 7           
|           |                       |                                                                                           |             
|           | Item 4.               | Controls and Procedures                                                                   | 7           
|           |                       |                                                                                           |             
|PART II.   | Other Information     |                                                                                          
|           |                       |                                                                                          
|           | Item 1.               | Legal Proceedings                                                                         | 8           
|           |                       |                                                                                           |             
|           | Item 1A               | Risk Factors                                                                              | 8           
|           |                       |                                                                                           |             
|           | Item 2.               | Unregistered Sales of Equity Securities and Use of Proceeds                               | 8           
|           |                       |                                                                                           |             
|           | Item 3.               | Defaults Upon Senior Securities                                                           | 9           
|           |                       |                                                                                           |             
|           | Item 4.               | Mine Safety Disclosures                                                                   | 9           
|           |                       |                                                                                           |             
|           | Item 5.               | Other Information                                                                         | 9           
|           |                       |                                                                                           |             
|           | Item 6.               | Exhibits                                                                                  | 9           
|           |                       |                                                                                           |             
|SIGNATURES |                       | 10                                                                                       



2







Global Health Voyager, Inc. and Subsidiaries

(A Development Stage Company)

Consolidated Balance Sheets



|                                                                                                                                                                        |  | June 30,
2012 |             |   | December 31, 2011 |  
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | ------------- | ----------- | - | ----------------- | -
|                                                                                                                                                                        |  | (Unaudited)   |             |   | (Restated)        |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|ASSETS                                                                                                                                                                  |  |               |             |   |                   |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|CURRENT ASSETS                                                                                                                                                          |  |               |             |   |                   |  
|Cash and equivalents                                                                                                                                                    |  | $             | 2,000       |   |                   | $
|Prepaid expenses                                                                                                                                                        |  |               | -           |   |                   |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|TOTAL ASSETS                                                                                                                                                            |  | $             | 2,000       |   |                   | $
|                                                                                                                                                                        |  |               |             |   |                   |  
|LIABILITIES AND STOCKHOLDERS'
    DEFICIT                                                                                                                               |  |               |             |   |                   |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|CURRENT LIABILITIES                                                                                                                                                     |  |               |             |   |                   |  
|Accounts payable                                                                                                                                                        |  | $             | 573,219     |   |                   | $
|Accrued liabilities                                                                                                                                                     |  |               | 1,317,755   |   |                   |  
|Accrued liabilities, related parties                                                                                                                                    |  |               | 1,043,168   |   |                   |  
|Notes payable                                                                                                                                                           |  |               | 1,249,470   |   |                   |  
|Notes payable, related party                                                                                                                                            |  |               | 42,777      |   |                   |  
|Convertible notes payable                                                                                                                                               |  |               | 867,839     |   |                   |  
|Accrued litigation settlements                                                                                                                                          |  |               | 113,178     |   |                   |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|TOTAL CURRENT LIABILITIES                                                                                                                                               |  |               | 5,207,406   |   |                   |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|LONG TERM LIABILITIES                                                                                                                                                   |  |               |             |   |                   |  
|Convertible notes payable                                                                                                                                               |  |               | 354,592     |   |                   |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|TOTAL LIABILITIES                                                                                                                                                       |  |               | 5,561,998   |   |                   |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|COMMITMENTS AND CONTINGENCIES                                                                                                                                           |  |               |             |   |                   |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|STOCKHOLDERS' DEFICIT                                                                                                                                                   |  |               |             |   |                   |  
|Preferred stock, $0.001
    par value, 5,000,000 shares authorized; 0 shares issued and outstanding                                                                     |  |               | -           |   |                   |  
|Common stock; $0.001 par
    value; 1,000,000,000 shares authorized; 45,820,431 and 35,912,800 shares issued and outstanding at June 30, 2012 and
    December 31, 2011 |  |               | 45,820      |   |                   |  
|Additional paid-in capital                                                                                                                                              |  |               | 4,532,783   |   |                   |  
|Deficit accumulated during the development stage                                                                                                                        |  |               | (10,138,601 | ) |                   |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|TOTAL STOCKHOLDERS' DEFICIT                                                                                                                                             |  |               | (5,559,998  | ) |                   |  
|                                                                                                                                                                        |  |               |             |   |                   |  
|TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                                                                                                                             |  | $             | 2,000       |   |                   | $





See accompanying notes to consolidated financial statements.





F-1







Global Health Voyager, Inc. and Subsidiaries

(A Development Stage Company)

Consolidated Statements of Operations

(unaudited)



|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  | Cumulative from |           
|---------------------------------------------------------------------- |  | ------------------ | ---------- | - | ---------------- | - | ---------- | -------------------------- |  | - | ------------- | - |  | --------------- | ----------
|                                                                       |  | Three Months Ended |            |   | Six Months Ended |   |            | June 4, 1999(inception) to | 
|                                                                       |  | June 30,  2012     |            |   | June 30, 2011    |   |            | June 30, 2012              |  |   | June 30, 2011 |   |  | June 30, 2012   |           
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|REVENUES                                                               |  | $                  | -          |   |                  | $ | -          |                            |  | $ | -             |   |  | $               | -         
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|COSTS AND EXPENSES                                                     |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|General and administrative                                             |  |                    | 99,475     |   |                  |   | 130,189    |                            |  |   | 207,943       |   |  |                 | 225,518   
|Depreciation and amortization                                          |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|Impairment of film costs                                               |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|Impairment of related party receivables                                |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|Inventory write-down                                                   |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|Loss on litigation settlement                                          |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|TOTAL COSTS AND EXPENSES                                               |  |                    | 99,475     |   |                  |   | 130,189    |                            |  |   | 207,943       |   |  |                 | 225,518   
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|LOSS FROM OPERATIONS                                                   |  |                    | (99,475    | ) |                  |   | (130,189   | )                          |  |   | (207,943      | ) |  |                 | (225,518  
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|OTHER INCOME (EXPENSE)                                                 |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|Other income                                                           |  |                    | -          |   |                  |   | -          |                            |  |   | 630           |   |  |                 | -         
|Other expense                                                          |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|Interest expense                                                       |  |                    | (58,509    | ) |                  |   | (38,359    | )                          |  |   | (116,446      | ) |  |                 | (73,782   
|Interest expense, related party                                        |  |                    | (1,294     | ) |                  |   | (12,681    | )                          |  |   | (2,613        | ) |  |                 | (24,190   
|Loan fees                                                              |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|Debt forgiven                                                          |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|Legal fees forgiven                                                    |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|Provision for common stock subscription receivable                     |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|TOTAL OTHER EXPENSES, NET                                              |  |                    | (59,803    | ) |                  |   | (51,040    | )                          |  |   | (118,429      | ) |  |                 | (97,972   
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|LOSS BEFORE PROVISION FOR
    INCOME TAXES AND NONCONTROLLING INTEREST |  |                    | (159,278   | ) |                  |   | (181,229   | )                          |  |   | (326,372      | ) |  |                 | (323,490  
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|PROVISION FOR INCOME TAXES                                             |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | 800       
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|LOSS BEFORE NON-CONTROLLING INTEREST                                   |  |                    | (159,278   | ) |                  |   | (181,229   | )                          |  |   | (326,372      | ) |  |                 | (324,290  
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|LESS: LOSS ATTRIBUTABLE TO NON-CONTROLLING                             |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|INTEREST                                                               |  |                    | -          |   |                  |   | -          |                            |  |   | -             |   |  |                 | -         
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|NET LOSS ATTRIBUTABLE TO GLOBAL HEALTH VOYAGER, INC. AND SUBSIDIARIES  |  | $                  | (159,278   | ) |                  | $ | (181,229   | )                          |  | $ | (326,372      | ) |  | $               | (324,290  
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|NET LOSS PER SHARE:                                                    |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|BASIC AND DILUTED                                                      |  | $                  | (0.00      | ) |                  | $ | (0.01      | )                          |  | $ | (0.01         | ) |  | $               | (0.01     
|                                                                       |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|WEIGHTED AVERAGE SHARES OUTSTANDING:                                   |  |                    |            |   |                  |   |            |                            |  |   |               |   |  |                 |           
|BASIC AND DILUTED                                                      |  |                    | 44,862,320 |   |                  |   | 26,601,434 |                            |  |   | 41,957,186    |   |  |                 | 26,543,093



See accompanying notes to consolidated
financial statements.



F-2







Global Health Voyager, Inc. and Subsidiaries

(A Development Stage Company)

Consolidated Statements of Cash Flows

(unaudited)



|                                                                                |  |                      |          |                                |               |   |          |                   |  | Cumulative from |            
|------------------------------------------------------------------------------- |  | -------------------- | -------- | ------------------------------ | ------------- | - | -------- | ----------------- |  | --------------- | -----------
|                                                                                |  | Six
    Months Ended |          | June
    4, 1999(inception) to |              
|                                                                                |  | June 30, 2012        |          |                                | June 30, 2011 |   |          | June
    30, 2012 | 
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|CASH FLOWS FROM OPERATING ACTIVITIES:                                           |  |                      |          |                                |               |   |          |                   |  |                 |            
|Net loss before non-controlling interest                                        |  | $                    | (326,372 | )                              |               | $ | (324,290 | )                 |  | $               | (10,171,601
|Adjustments to reconcile
    net loss to net cash used in operating activities: |  |                      |          |                                |               |   |          |                   |  |                 |            
|Gain on conversion of notes                                                     |  |                      | (630     | )                              |               |   | -        |                   |  |                 | (630       
|Provision for prepayment                                                        |  |                      | -        |                                |               |   | -        |                   |  |                 | 73,732     
|Amortized interest on warrants                                                  |  |                      | 2,686    |                                |               |   | -        |                   |  |                 | 5,703      
|Depreciation and amortization                                                   |  |                      | -        |                                |               |   | -        |                   |  |                 | 132,077    
|Impairment loss                                                                 |  |                      | -        |                                |               |   | -        |                   |  |                 | 336,773    
|Inventory write-down                                                            |  |                      | -        |                                |               |   | -        |                   |  |                 | 24,820     
|Impairment of related party receivables                                         |  |                      | -        |                                |               |   | -        |                   |  |                 | 35,383     
|Operating expenses paid by reducing note receivable                             |  |                      | -        |                                |               |   | -        |                   |  |                 | 10,000     
|Stock issued for services                                                       |  |                      | 22,988   |                                |               |   | 13,500   |                   |  |                 | 1,431,927  
|Deferred compensation                                                           |  |                      | -        |                                |               |   | -        |                   |  |                 | 10,417     
|Stock issued for loan fees                                                      |  |                      | -        |                                |               |   | -        |                   |  |                 | 423,000    
|Stock options issued for services                                               |  |                      | -        |                                |               |   | -        |                   |  |                 | 60,370     
|Legal fees forgiven                                                             |  |                      | -        |                                |               |   | -        |                   |  |                 | (12,296    
|Debts forgiven                                                                  |  |                      | -        |                                |               |   | -        |                   |  |                 | (290,595   
|Provision for common stock subscription receivable                              |  |                      | -        |                                |               |   | -        |                   |  |                 | 89,468     
|Amount attributable to non-controlling interest                                 |  |                      | -        |                                |               |   | -        |                   |  |                 | 33,000     
|Beneficial conversion of debt and accrued interest                              |  |                      | -        |                                |               |   | -        |                   |  |                 | 770,275    
|Changes in assets and liabilities:                                              |  |                      |          |                                |               |   |          |                   |  |                 |            
|Interest receivable                                                             |  |                      | -        |                                |               |   | -        |                   |  |                 | (19,986    
|Inventory                                                                       |  |                      | -        |                                |               |   | -        |                   |  |                 | (24,820    
|Prepaid expenses                                                                |  |                      | -        |                                |               |   | (6,271   | )                 |  |                 | (79,920    
|Other assets                                                                    |  |                      | -        |                                |               |   | -        |                   |  |                 | (24,000    
|Accrued litigation settlements                                                  |  |                      | -        |                                |               |   | -        |                   |  |                 | 100,000    
|Accounts payable and accrued expenses                                           |  |                      | 101,295  |                                |               |   | 107,799  |                   |  |                 | 1,935,608  
|Accrued expenses, related parties                                               |  |                      | 75,000   |                                |               |   | 99,190   |                   |  |                 | 1,399,954  
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|Net cash used in operating activities                                           |  |                      | (125,032 | )                              |               |   | (110,072 | )                 |  |                 | (3,751,341 
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|CASH FLOWS FROM INVESTING ACTIVITIES:                                           |  |                      |          |                                |               |   |          |                   |  |                 |            
|Notes receivable from officer                                                   |  |                      | -        |                                |               |   | -        |                   |  |                 | (45,048    
|Collection of notes receivable from officer                                     |  |                      | -        |                                |               |   | -        |                   |  |                 | 35,048     
|Notes receivable, related parties                                               |  |                      | -        |                                |               |   | -        |                   |  |                 | (50,000    
|Collection of notes receivable, related parties                                 |  |                      | -        |                                |               |   | -        |                   |  |                 | 50,000     
|Investment in property and equipment                                            |  |                      | -        |                                |               |   | -        |                   |  |                 | (18,879    
|Investment in film costs                                                        |  |                      | -        |                                |               |   | -        |                   |  |                 | (133,005   
|Investment in web site development costs                                        |  |                      | -        |                                |               |   | -        |                   |  |                 | (292,968   
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|Net cash used in investing activities                                           |  |                      | -        |                                |               |   | -        |                   |  |                 | (454,852   
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|CASH FLOWS FROM FINANCING ACTIVITIES:                                           |  |                      |          |                                |               |   |          |                   |  |                 |            
|Proceeds from issuance of common stock                                          |  |                      | -        |                                |               |   | -        |                   |  |                 | 1,254,154  
|Payment of offering costs                                                       |  |                      | -        |                                |               |   | -        |                   |  |                 | (66,450    
|Proceeds from notes payable                                                     |  |                      | 94,100   |                                |               |   | 50,000   |                   |  |                 | 1,656,272  
|Proceeds from notes payable, related party                                      |  |                      | 2,000    |                                |               |   | 36,012   |                   |  |                 | 688,496    
|Payments of notes payable                                                       |  |                      | (19,135  | )                              |               |   | -        |                   |  |                 | (221,051   
|Payments of notes payable, related party                                        |  |                      | (3,233   | )                              |               |   | -        |                   |  |                 | (423,529   
|Proceeds from issuance of convertible notes                                     |  |                      | 52,501   |                                |               |   | 350,000  |                   |  |                 | 1,320,301  
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|Net cash provided by financing activities                                       |  |                      | 126,233  |                                |               |   | 436,012  |                   |  |                 | 4,208,193  
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|NET INCREASE IN CASH AND EQUIVALENTS                                            |  |                      | 1,201    |                                |               |   | 325,940  |                   |  |                 | 2,000      
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|CASH AND EQUIVALENTS, Beginning of
    period                                   |  |                      | 799      |                                |               |   | 1        |                   |  |                 | -          
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|CASH AND EQUIVALENTS, End of period                                             |  | $                    | 2,000    |                                |               | $ | 325,941  |                   |  | $               | 2,000      
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|SUPPLEMENTAL DISCLOSURES OF
    CASH FLOW INFORMATION:                          |  |                      |          |                                |               |   |          |                   |  |                 |            
|Cash paid during the period for:                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|Interest paid                                                                   |  | $                    | 1,962    |                                |               | $ | -        |                   |  | $               | 23,473     
|Income taxes paid                                                               |  | $                    | -        |                                |               | $ | -        |                   |  | $               | 4,000      
|                                                                                |  |                      |          |                                |               |   |          |                   |  |                 |            
|NONCASH FINANCING ACTIVITIES:                                                   |  |                      |          |                                |               |   |          |                   |  |                 |            
|Beneficial conversion of debt and accrued interest                              |  | $                    | -        |                                |               | $ | -        |                   |  | $               | 770,275    
|Stock issued for services                                                       |  | $                    | 22,988   |                                |               | $ | 13,500   |                   |  | $               | 1,431,927  
|Stock issued for loan fees                                                      |  | $                    | -        |                                |               | $ | -        |                   |  | $               | 423,000    
|Stock options issued for services                                               |  | $                    | -        |                                |               | $ | -        |                   |  | $               | 60,370     



See accompanying notes to consolidated financial
statements.

F-3







GLOBAL HEALTH VOYAGER, INC. AND SUBSIDIARIES

(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2012 and 2011 (UNAUDITED)
AND DECEMBER 31, 2011 (RESTATED)



NOTE 1. NATURE OF BUSINESS



NT Media Corp. of California, Inc. (“NT
Media”) was incorporated in the State of Delaware on March 14, 2000. On April 17, 2001, in connection with a stock exchange
agreement, NT Media acquired 100% of the outstanding stock of eCast Media Corporation, Inc. (“eCast”).



eCast was a production, aggregation,
and distribution company, of on-and-offline content, the management of on-and-offline talent and literary clients, and strategic
consulting services. Due to losses and continued inability to generate significant revenue, the Company suspended eCast.



On November 1, 2010, NT Media’s
Board of Directors (“BOD”) and management decided to change its business focus from entertainment and website development
to websites dedicated to the facilitation of medical tourism. Management believes that due to the potential growth in the medical
tourism industry (“MTI”), it is a better use of its resources. NT Media discontinued operations and maintenance of
web destinations it launched in the last several years, as it has transitioned operations toward the development of one or more
medical tourism websites.



On April 20, 2011, the NT Media launched
its initial medical tourism website called www.globalhealthvoyager.com. The website is designed to be an information
portal for users to facilitate medical procedures, hospitals, and clinics overseas. The website is updated regularly and will continue
to be enhanced over time.



On August 10, 2011, NT Media
changed its name to Global Health Voyager, Inc. (the “Company”) and discontinued developing media and
entertainment assets and channels. In 2011, the Company phased out several websites,
including www.neurotrash.tv, www.singlefathernetwork.com, and www.stemcellstalk.com, as it
shifted its focus to the Company’s recently launched medical tourism web portal.



NOTE 2. GOING CONCERN AND MANAGEMENT’S
PLANS



The accompanying consolidated financial
statements were prepared in conformity with accounting principles generally accepted in the United States (“US GAAP”),
which contemplates continuation of the Company as a going concern. As of and for the six months ended June 30, 2012, the Company
incurred a net loss of $326,372, had an accumulated deficit of $10,138,601, as well as a working capital deficit of $5,205,406.
These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. These consolidated financial
statements do not include any adjustments that might result from the outcome of this uncertainty.



For the Company to meet its financial
obligations, it will continue to attempt to sell equity or incur debt, although there cannot be any assurance the Company will
be successful in doing so.



The Company plans to take advantage
of the growth in the MTI as a facilitator through joint ventures, partnerships, and agreements. The Company intends to enter into
agreements with hospitals, insurance companies, travel agencies, facilitators, and other healthcare providers to establish a creditable
network and effectively obtain a strong market presence within the MTI. The Company will attempt to enter into partnerships with
other entities to mitigate some of the financial risk. The Company’s ability to develop these relationships is principally
dependent on its ability to raise capital to fund the projects, which is difficult due to its current financial condition and lack
of history in the market.



The Company’s current business
operations are focused on facilitating medical procedures in the MTI, including building a web-based platform, building relations
with hospitals and healthcare providers both in the US and abroad, and vertical social and professional networks.



The Company’s strategy is to obtain
market share within the MTI by building a web-based platform that would enhance its web presence and market the Company as a one-stop-shop
for medical tourism needs. The Company has attended and plans to continue to attend various industry conferences and trade shows
to further build relationships and partnerships within the healthcare industry which would enhance the Company’s position
within the MTI.



F-4







NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES



Basis of Presentation



Because the Company has not generated
any revenue, it is considered a development stage company. Consequently, the accompanying consolidated financial statements were
prepared using the accounting formats prescribed for development stage enterprises in accordance with ASC 915, “Development
Stage Entities”. The Company’s year end is December 31st.



The consolidated interim financial information
as of June 30, 2012 and for the six and three month periods ended June 30, 2012 and 2011 was prepared without audit, pursuant to
the rules and regulations of the SEC. Certain information and footnote disclosures, which are normally included in consolidated
financial statements prepared in accordance with US GAAP was not included. The interim consolidated financial information should
be read in conjunction with the Financial Statements and the notes thereto, included in the Company’s Annual Report on Form
10-K for the fiscal year ended December 31, 2011, previously filed with the SEC.



In the opinion of management, all adjustments
(which include normal recurring adjustments) necessary to present a fair statement of the Company’s consolidated financial
position as of June 30, 2012, its consolidated results of operations and cash flows for the six and three month periods ended June
30, 2012 and 2011, as applicable, were made. The interim results of operations are not necessarily indicative of the operating
results for the full fiscal year or any future periods.



Basis of Consolidation



The consolidated financial statements
include the accounts of Global Health Voyager, its wholly owned subsidiary, eCast, and its 51% owned subsidiary, SUD. eCast and
SUD are inactive. All significant intercompany accounts and transactions were eliminated in consolidation.



Cash and Equivalents



Cash and equivalents consist of cash
on deposit and investments with original maturities of three months or less.



Use of Estimates



The preparation of consolidated financial
statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amount of
assets and liabilities and disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual
results could differ from those estimates.



Equipment and Depreciation



Equipment is recorded at cost. Expenditures
for major additions and improvements are capitalized and minor replacements, maintenance, and repairs expensed as incurred. When
equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any reselling
gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful
lives of the related assets using the straight-line method for consolidated financial statements purposes. There was no depreciation
recorded for the six and three months ended June 30, 2012 and 2011.



Fair Value of Financial Instruments



The carrying value of cash, deferred
revenue, accounts payable, and accrued expenses are approximately at fair value.



F-5









Revenue Recognition



Revenues are recognized on an accrual
basis. Generally, revenues will be recognized when persuasive evidence of an arrangement exists, services have been rendered, the
price is fixed and determinable, and collectability is reasonably assured.



Concentrations of Credit Risk



The Company maintains all cash in bank
accounts, which at times may exceed federally insured limits. The Company has not experienced a loss in such accounts.



Income Taxes



The Company follows the liability method
of accounting for income taxes pursuant to ASC 740, “Accounting for Income Taxes”. Under ASC 740 deferred income taxes
are recorded to reflect tax consequences on future years for the differences between the tax bases of assets and liabilities and
their financial reporting amounts at each period-end.



Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of
existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carryforwards,
and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates
is recognized in income in the period that includes the enactment date.



The components of the deferred tax assets
and liabilities are individually classified as current and non-current based on their characteristics. Deferred tax assets are
reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the
deferred tax assets will not be realized.



The Company follows ASC 740-10, “Accounting
for Uncertainty in Income Taxes”. As a result, the Company applies a more-likely-than-not recognition threshold for all tax
uncertainties. ASC 740-10 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained
upon examination by the taxing authorities. As a result of implementing ASC 740-10, the Company’s management reviewed the
Company’s tax positions and determined there were no outstanding, or retroactive tax positions with less than a 50% likelihood
of being sustained upon examination by the taxing authorities, therefore the implementation of this standard has not had a material
affect on the Company.



Based on its evaluation, the Company
concluded there were no significant uncertain tax positions requiring recognition in its financial statements as of June 30, 2012
and December 31, 2011.



The Company does not have any unrecognized
tax benefits as of June 30, 2012 and December 31, 2011 which if recognized would affect the Company’s effective income tax
rate.



The Company’s policy is to recognize
interest and penalties related to income tax issues as components of income tax expense. The Company did not recognize or incur
any accrual for interest and penalties relating to income taxes during the six and three months ended June 30, 2012 and 2011.



California law requires payments of
a minimum annual franchise tax of $800 by corporations that are qualified to do business in California. The Company has not paid
the $800 minimum tax for 2012 and 2011, nor has it filed its tax returns, causing the California Secretary of State to forfeit
its corporate status. The Company is in the process of filing all delinquent corporate tax returns to re-establish its corporate
status. The Company expects to be reinstated by the end of 2012.



Impairment of Long-Lived Assets



The Company adopted ASC 360, “Accounting
for the Impairment or Disposal of Long-Lived Assets”. The Company evaluates its long-lived assets by measuring the carrying
amounts of assets against the estimated undiscounted future cash flows associated with them. At the time the carrying value of
such assets exceeds the fair value of such assets, impairment is recognized.



F-6







Advertising Costs



Advertising costs are expensed as incurred.
The Company did not incur any advertising costs during the six months ended June 30, 2012 and 2011.



Loss per Share



The Company computes loss per share
in accordance with ASC 260-10-45, “Earnings per Share”. The Statement requires dual presentation of basic and diluted
Earnings per Share (“EPS”) on the face of the income statement for all entities with complex capital structures and
requires a reconciliation of the numerator and the denominator of the basic EPS computation to the numerator and the denominator
of the diluted EPS computation. The Company computes basic and diluted net loss per share by dividing the net loss available to
common stockholders for the six and three months ended June 30, 2012 and 2011 by the weighted average number of shares of common
stock outstanding during the six and three months ended June 30, 2012 and 2011. Common equivalent shares related to stock options
and warrants were excluded from the computation of basic and diluted EPS for the six and three months ended June 30, 2012 and 2011
because their effect is anti-dilutive.



Stock based compensation to other
than employees



The Company accounts for
equity instruments issued for the receipt of goods or services from other than employees in accordance with ASC 718,
“Accountingfor Stock-Based Compensation,” and the conclusions reached by ASC 505-50,
“Accounting for Equity Instruments That Are Issued to Other Than Employees for Acquiring or in Conjunction with Selling
Goods or Services”. Costs are measured at the estimated fair market value of the
consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably determinable.
The value of equity instruments issued as consideration for other than employee services is determined on the earlier of a
performance commitment or completion of performance by the provider of goods or services as defined by ASC 505-50. In the
case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the
consulting agreement.



Recently Issued Accounting Pronouncements



In May 2011, the FASB issued
Accounting Standard Update (“ASU”) No. 2011-04, “Amendments to Achieve Common Fair Value Measurement and
Disclosure Requirements in US GAAP and IFRSs”, which is adopted for fiscal years, and interim periods beginning after
December 15, 2011 for public entities with retrospective application. There was no material impact on our consolidated
financial statements upon adoption.



In June 2011, the FASB issued ASU No.
2011-05, “Presentation of Comprehensive Income”. Under the amendments in this ASU, an entity has two options for presenting
its total comprehensive income: to present total comprehensive income and its components along with the components of net income
in a single continuous statement, or in two separate but consecutive statements. The amendments in this ASU are required to be
applied retrospectively and are effective for fiscal years, and interim periods within those years, beginning after December 15,
2011, with early adoption permitted. There was no material impact on our consolidated financial statements upon adoption.



In September 2011, the FASB
issued ASU No. 2011-08, Intangibles—Goodwill and Other (Topic 350)—Testing Goodwill for Impairment, to simplify
how entities test goodwill for impairment. ASU No. 2011-08 allows entities to first assess qualitative factors to determine
whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If greater than
50% likelihood exists that the fair value is less than the carrying amount then a two-step goodwill impairment test as
described in Topic 350 must be performed. The guidance provided by this update became effective for annual and interim
goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The Company adopts this ASU beginning
with its Quarterly Report on Form 10-Q for the six and three months ended June 30, 2012. There was no material impact on our
consolidated financial statements upon adoption.



F-7







In December 2011, the FASB issued ASU No. 2011-11, “Balance Sheet (Topic 210): Disclosure about Offsetting Assets and Liabilities,” (“ASU
2011-11”). ASU 2011-11 enhances disclosure regarding financial instruments and derivative instruments. Entities are required
to provide both net information and gross information for these assets and liabilities in order to enhance comparability between
those entities that prepare their financial statements on the basis of US GAAP and those entities that prepare their financial
statements on the basis of IFRS. This new guidance is to be applied retrospectively. The adoption of these provisions did not have
a material impact on the Company’s consolidated s financial statements.



On July 27, 2012, the FASB
issued ASU 2012-02, Intangibles-Goodwill and Other (Topic 350) - Testing Indefinite-Lived Intangible Assets for
Impairment.  The ASU provides entities with an option to first assess qualitative factors to determine whether events or
circumstances indicate that it is more likely than not that the indefinite-lived intangible asset is impaired.  If an
entity concludes that it is more than 50% likely that an indefinite-lived intangible asset is not impaired, no further
analysis is required.  However, if an entity concludes otherwise, it would be required to determine the fair value of
the indefinite-lived intangible asset to measure the amount of actual impairment, if any, as currently required under US
GAAP. The ASU is effective for annual and interim impairment tests performed for fiscal years beginning after September 15,
2012.  Early adoption is permitted. The adoption of this pronouncement will not have a material impact on its financial
statements.



There are no other recently issued accounting
standards not yet adopted that would have a material effect on the Company’s consolidated financial statements.



NOTE 4. PREPAID EXPENSES



Prepaid expenses represent fair value
of stock issued for consulting services for the period from June 12, 2011 to June 11, 2012.



NOTE 5. NOTES PAYABLE



During the quarter ended March 31, 2011,
the Company issued a promissory note of $10,000 bearing interest at 12% due June 2011. No payments were made on this note. It was
verbally extended and is not considered in default.



During the quarter ended March 31, 2011,
the Company issued notes of $17,135 at 12% and due at various dates through June 2011. $17,000 of principal was repaid. The notes
were verbally extended and are not considered in default.



During the quarter ended June 30, 2011,
the Company issued promissory notes totaling $40,000 at 12% due July 2011. No payments were made on these notes. They were verbally
extended and not are considered in default.



During the quarter ended December 31,
2011, the Company issued notes of $64,000 at 12% and due at various dates through February 25, 2012. $24,000 of principal was repaid.
These notes were verbally extended and are payable upon demand.



During the quarter ended December 31,
2011, the note payable-related party of $6,265 without interest and due on demand was reclassified from related party to unrelated
party, $265 of which was repaid.



During the quarter ended March 31, 2012,
the Company issued a note of $12,000 at 12% and due on May 2, 2012. The note was verbally extended until September 1, 2012.



The Company
also issued a note of $50,000 on March 13, 2012 and due on April 17, 2012. The interest for the note was $500. The note was verbally
extended for one month until May 25, 2012. The notes were verbally extended and are payable upon demand.



F-8







During the quarter ended March 31, 2012,
the Company repaid principal of $4,135 and interest of $565 for the notes with interest of 12%.



During the quarter ended June 30, 2012,
the Company issued notes of $3,600 and $3,500 at 12% and due on July 12 and 20, 2012, respectively. The notes were verbally renewed
and are payable upon demand.



The Company also issued
a bridge note of $25,000 on June 21, 2012 and due on July 30, 2012. The interest rate for the note was 5%. The note was
verbally renewed and is payable upon demand.



During the quarter ended June 30, 2012,
the Company repaid principal of $15,000 of the 12% interest note and interest of $1,100 of the note with interest of 12%.



At June 30, 2012 and December 31, 2011,
notes payable to non-related parties consisted of the following:



|                                                        |  | 2012 |           |  | 2011 |  
|------------------------------------------------------- |  | ---- | --------- |  | ---- | -
|Interest at 12%, due on demand                          |  | $    | 981,720   |  |      | $
|Interest at 15%, due on demand                          |  |      | 20,000    |  |      |  
|Interest at 10%, due on demand                          |  |      | 128,000   |  |      |  
|Interest at 12.5%, due on demand                        |  |      | 38,750    |  |      |  
|Interest at 5%, bridge note, due on demand              |  |      | 25,000    |  |      |  
|Interest at approximately $500 per month, due on demand |  |      | 50,000    |  |      |  
|Notes payable bearing no interest, due on demand        |  |      | 6,000     |  |      |  
|Total Due                                               |  | $    | 1,249,470 |  |      | $



NOTE 6. NOTES PAYABLE, RELATED PARTY



During the quarter ended March 31, 2011,
the Company issued notes of $8,760 to its President at 12% and due at various dates through June 2011. No principal payments were
made. The notes were verbally extended and are not considered in default.



During the quarter ended June 30, 2011,
the Company issued notes of $10,117 to its President at 12% and due at various dates through July 2011. No principal payments were
made. The notes were verbally extended and are not considered in default.



During the quarter ended September 31,
2011 and December 31, 2011, the Company paid $6,000 and $2,317 in interest to its President, respectively. No principal payments
were made.



During the quarter ended December 31,
2011, the Company paid $1,683 in principal due on notes from related parties.



During the quarter ended December 31,
2011, the note payable-related party of $6,265 without interest and due on demand was reclassified from related party to unrelated
party, $265 of which was repaid.



During the quarter ended December 31,
2011, the Company’s president had $10,136 in personal charges made on the Company credit card. The charges were netted against
the notes payable to the Company’s President.



During the quarter ended March 31, 2012,
the Company repaid principal of $533 and interest of $11.



During the quarter ended June 30, 2012,
the Company issued note of $2,000 to its president at 12% and due at September 27, 2012.



During the quarter ended June 30, 2012,
the Company repaid principal of $2,700 and interest of $286.



F-9







At June 30, 2012 and December 31, 2011,
notes payable to related parties was:



|                                                                         |  | 2012 |        |  | 2011 |  
|------------------------------------------------------------------------ |  | ---- | ------ |  | ---- | -
|Notes payable to Company’s
    President, Interest at 12%, due on demand |  | $    | 42,777 |  |      | $
|                                                                         |  | $    | 42,777 |  |      | $



NOTE 7. CONVERTIBLE NOTES PAYABLE



At December 31, 2010, the Company had
$625,600 of 6% subordinated convertible notes outstanding. The notes are due to a related party who owned less than 1% of the issued
and outstanding stock of the Company as of December 31, 2010. As of December 31, 2011, all convertible notes payable related party
were transferred to unrelated party. All notes are convertible to common shares, $0.001 par value, at the average bid price of
the common stock for the five trading days immediately preceding the conversion date. The notes are convertible when the Company’s
securities are trading publicly and the underlying stock of the debenture has been registered with the SEC and declared effective.
It is mandatory that the notes to be converted on the sixth and seventh year of their anniversary date or are due and payable in
the event that the Company’s shares of common stock are not publicly traded. All of these notes are classified as a current
liability at December 31, 2010 and June 30, 2012.



As of December 31, 2011, the Company
issued $350,000 ($150,000 and $200,000, respectively) in convertible notes payable, bearing interest at 10%, due June 2014. All
notes are convertible to common shares, $0.001 par value, at the lower of $0.10 or 80% of the average closing bid during the five
days immediately prior to the conversion date. The Company also issued warrants to purchase up to 1,750,000 shares of common stock
for $0.10 as part of the convertible note issuance. Beneficial conversion feature (“BCF”) is contingent on the Company’s
average stock as determined by the conversion formula. This BCF is not recorded and will be recorded when the contingency is resolved.



The value of warrants was
determined by using the Black-Scholes pricing model with the following assumptions: discount
rate– 0.93%; dividend yield–0%; expected volatility– 70%
and term of 3 years. The value of the warrants was $16,110 ($6,904 and $9,206, respectively) at grant date.



The fair value (“FV”) of
the warrants was allocated to the total proceeds from the loans, based on the relative FV of the warrants and debts, as unamortized
interest totaling $16,110, to be amortized over the term of the loans. The warrants were classified as equity. The amortized interest
expense for the six months ended June 30, 2012 and 2011 was $2,686 and $0; $1,343 and $0 was for the three months ended June 30,
2012 and 2011, respectively. The unamortized interest on warrants was $10,407 as of June 30, 2012.



$597,400 of convertible notes payable
was transferred to convertible note payable – unrelated party and $28,200 of the notes was converted as of December 31, 2011.



On February 8, 2012, the Company converted
a note with principal of $16,883 and interest of $1,117 into 1,800,000 shares of Common Stock at conversion price of $0.01 per
share.



On February 9, 2012, the Company converted
a note of $18,000 of accrued interest into 1,800,000 shares of Common Stock at conversion price of $0.01 per share



On February 27, 2012, the Company converted
a note with principal of $15,030 into 1,800,000 shares of Common Stock at conversion price of $0.008 per share.



On March 29, 2012, the Company converted
a note with principal of $3,049 and interest of $4,951 into 2,000,000 shares of Common Stock at conversion price of $0.004 per
share.



On April 4, 2012, the Company issued
convertible notes of $37,500 at interest 8% and due on January 9, 2013.



On April 27, 2012, the Company issued
convertible notes of $5,000 and $10,000 at interest 12% and due on April 27, 2015.



F-10







As of May 14, 2012, the Company converted
interest of $7,705 into 2,027,631 shares of the Company’s Common Stock at conversion price of $0.0038 per share.



At June 30, 2012 and December 31, 2011,
convertible notes payable to non-related parties consisted of the following:



|                                               |  | 2012 |           |   | 2011 |  
|---------------------------------------------- |  | ---- | --------- | - | ---- | -
|Interest at 6%, due on demand                  |  | $    | 282,200   |   |      | $
|Interest at 6%, transferred from related party |  |      | 625,600   |   |      |  
|Interest at 10%, due on demand                 |  |      | 350,000   |   |      |  
|Interest at 8%, due in 2013                    |  |      | 37,500    |   |      |  
|Interest at 12%, due in year 2015              |  |      | 15,000    |   |      |  
|Total                                          |  |      | 1,310,300 |   |      |  
|Less: Notes payable converted                  |  |      | (77,462   | ) |      |  
|Less: Current portion                          |  |      | (867,839  | ) |      |  
|Less: Unamortized interest on warrants         |  |      | (10,407   | ) |      |  
|Convertible notes payable, noncurrent          |  | $    | 354,592   |   |      | $



Interest expense on these notes for
the six months ended June 30, 2012 and 2011 was $43,748 and $18,768; $22,248 and $9,384 for the three months ended June 30, 2012
and 2011 respectively.



NOTE 8. STOCKHOLDERS’ DEFICIT



In June 2011, the Company issued 300,000
shares of common stock as payment for marketing services. The FV of the stock on the day of issuance was $13,500.



In September 2011, the Company issued
1,120,000 shares of common stock to consultants for services rendered to the Company. The Company recorded the expense at the FV
of the shares of $324,800.



On September 30, 2011, the Company entered
various agreements to convert $36,488 of related party convertible debt and accrued interest into 2,606,285 shares of common stock.
The FV of the stock on the date of agreement and issuances was $573,383. The Company recorded a loss on settlement of debt of $536,895,
included in other expense.



In December 2011, the Company issued
700,000, 700,000, 400,000 and 600,000 shares of restricted common stock, respectively, as payment for services provided by four
officers of the Company. The FV of the stock on the day of issuance was $96,000.



In January 2012, the Company
issued 480,000 shares of restricted common stock to a marketing consultant company, as payment for services to be provided
from June 12, 2011 to June 11, 2012. The FV of the stock on the day of issuance was $16,800. As of June 30, 2012, $16,800 was
fully amortized.



Warrants



On June 30, 2011, the Company issued
warrants to purchase 1,750,000 shares of its common stock at $0.10 per share as part of convertible note issuances.



Options



There were no options granted during
the six months ended June 30, 2012 and 2011.



F-11







Common stock purchase options and warrants
consisted of the following at June 30, 2012 and December 31, 2011:



|                                               |  |             |           |  | Weighted Average |   |      | Aggregated | 
|---------------------------------------------- |  | ----------- | --------- |  | ---------------- | - | ---- | ---------- | 
|                                               |  |             |           |  | Exercise         |   |      | Intrinsic  | 
|                                               |  | # of shares |           |  | Price            |   |      | Value      | 
|Options:                                       |  |             |           |  |                  |   |      |            | 
|Outstanding and exercisable, December 31, 2011 |  |             | -         |  |                  | $ | -    |            | 
|Granted                                        |  |             | -         |  |                  |   | -    |            | 
|Exercised                                      |  |             | -         |  |                  |   | -    |            | 
|Expired                                        |  |             | -         |  |                  |   | -    |            | 
|Outstanding and exercisable, June 30, 2012     |  |             | -         |  |                  |   | -    |            | 
|                                               |  |             |           |  |                  |   |      |            | 
|Warrants:                                      |  |             |           |  |                  |   |      |            | 
|Outstanding and exercisable, December 31, 2011 |  |             | -         |  |                  | $ | -    |            | 
|Granted                                        |  |             | 1,750,000 |  |                  |   | 0.10 |            | 
|Exercised                                      |  |             | -         |  |                  |   | -    |            | 
|Expired                                        |  |             | -         |  |                  |   | -    |            | 
|Outstanding and exercisable, June 30, 2012     |  |             | 1,750,000 |  |                  | $ | 0.10 |            | 



NOTE 9. COMMITMENTS AND CONTINGENCIES



Starting in 2006, the Company used the
offices of the Company’s President at no cost, which is expected to continue until adequate funds are available.



NOTE 10. LITIGATION



The Company is subject to various claims
covering a wide range of matters that arise in the ordinary course of its business activities. Management believes that any liability
that may ultimately result from the resolution of these matters will not have a material adverse effect on the financial condition
or results of operations of the Company.



During 2002, eCast, settled a lawsuit
with its prior landlord of $100,000 and unpaid interest $13,178. As of June 30, 2012 the balance $113,178 due for the settlement
had not been paid and is reflected as a current liability.



Management is aware of a threatened
litigation matter involving the nonpayment of approximately $9,000 in legal fees. Management is not aware of any attempts by the
claimant to pursue the litigation.



On November 1, 2010 the accounting firm
of A.J. Robbins, P.C. filed a lawsuit in the District Court, City and County of Denver, Colorado, seeking recovery of fees allegedly
owed for accounting services performed during 2004 to 2008. The claims have been asserted against the Company, a second corporate
defendant, and our CEO, as a result of a personal guarantee. On December 15, 2010, Defendants filed an Answer which asserted several
defenses. The parties exchanged initial disclosures, and the matter was set for trial commencing on December 5, 2011. On August
3, 2011 the parties entered into a settlement agreement whereby the Defendants in the case will jointly pay $85,000 to the plaintiffs.
The Company was responsible to pay 50% of the cash payments, the other 50% of which was the responsibility of a second defendant.
The cash payments were scheduled to be made in equal monthly payments over 7 months commencing on August 31, 2011. In consideration
of the settlement, the parties have executed a mutual release and have agreed to withdraw the lawsuit. The releases and withdrawal
are contingent upon the Company's full performance of the settlement agreement terms. As of August 16, 2012, out of the cash payments
that the Company was responsible for under the settlement agreement, $8,520.82 is still owed and unpaid. This balance due is for
part of the February 28, 2012 payment. Plaintiff has the right to get a judgment for $175,000 minus the payments that were made,
if we fail to perform under the terms of the settlement agreement and if they serve us with a notice of default, which they have
not.



On January 5, 2012, HIN, et al filed
a lawsuit at the Los Angeles Superior Court, against the Company. The lawsuit filed by Plaintiffs alleges and seeks damages in
the form of monetary relief for: 1) breach of contract; 2) conversion; and 3) Labor Code violations for failure to pay wages timely;
and seeks equitable remedies in the form of: 1) rescission of contract; 2) declaratory relief; and 3) injunctive relief.



F-12







The Company responded to this lawsuit by way of both
a General and Special Demurrer, asserting the Complaint filed by Plaintiffs must be dismissed as Plaintiff Corporation is not
in good standing in its state of incorporation, Delaware, and therefore does not have the right to pursue legal remedies. Further,
the Company asserts that Plaintiffs’ Complaint fails to state facts sufficient to constitute any cause of action against
the Company. The Company has also filed a Request for Judicial Notice of Plaintiff LLC’s corporate standing. The scheduled
hearing date for Company’s objection to the lawsuit was May 16, 2012. While the Company will defend this action, there can
be no assurance that the Company will prevail in the lawsuit. At this time, the Company cannot determine the amount of damages,
if any, it could be responsible for if it does not prevail in the lawsuit. If the Company were to lose the lawsuit, the Company
could be liable for damages of more than $90,000 and would be responsible for paying the principals of the lawsuit back wages,
penalties and interest.



On
April 20, 2012, Plaintiffs filed a First Amended Complaint, correcting the issues raised by the Defendant’s motion.
On May 4, 2012, prior to the hearing on the motions, opposing counsel and the Company’s counsel attended a Case
Management Conference and the court took the Company’s motion off calendar because the irregularities raised by our
motion had not been addressed. Thus, the May 16, 2012 motion hearing did not take place. The Court then set dates and
deadlines for our case.



The
Court set the trial date for April 2, 2013. The Final Status Conference is scheduled for March 27, 2013. The mediation
completion date is November 13, 2012 and the Post Mediation Status Conference is November 15, 2012. The Company has been
ordered to complete private panel mediation whereby the parties will split the fees.



NOTE 11. RESTATEMENT OF FINANCIAL
STATEMENTS



The
financial statements as of December 31, 2011 were restated to correct amortization of consulting services of $212,500 which
were substantially completed in the fourth quarter of 2011. The following table presents the effects of the restatement
adjustment on the accompanying consolidated balance sheet at December 31, 2011:



|Consolidated
    Balance Sheet                   |  | As
        Previously
        Reported |            |   | Restated |   |            | NetAdjustment | 
|------------------------------------------------ |  | -------------------------------------- | ---------- | - | -------- | - | ---------- | ------------- | 
|Prepaid expenses                                 |  | $                                      | 218,688    |   |          | $ | 6,188      |               | 
|Total assets                                     |  | $                                      | 219,487    |   |          | $ | 6,987      |               | 
|Deficit accumulated during the development stage |  | $                                      | (9,599,729 | ) |          | $ | (9,812,229 | )             | 
|Total stockholders’ deficit                      |  | $                                      | (5,104,031 | ) |          | $ | (5,316,531 | )             | 



There were no effects on the accompanying consolidated statements
of operations.



NOTE 12. SUBSEQUENT EVENTS



On July 2, 2012, the Company
entered into consulting agreements with three contractors to assist with the Company’s public awareness. The agreements
shall continue until December 25, 2012 with the option of an additional three or six month renewal. As compensation, the
Company will pay each contractor a consulting fee of $1,000 per month through issuance of the Company’s restricted
common stock calculated at 20% discount of the average closing price of the lowest five trading days in the prior 20 trading
days for a minimum period of six months. The first payment shall be made on the effective date of this agreement and
subsequent payments shall be made payable on the first business day of each month for the duration of this contract. The
expenses related to the project will be reimbursed by the Company.



On July 6, 2012, the Company converted
a note with principal of $4,000 into 2,000,000 shares of Common Stock at conversion price of $0.002 per share.



On July 19, 2012, the Company
entered into a Notes Purchase Agreement (“NPA”) with Asher Enterprises, Inc. (“Asher”), a Delaware
corporation (“Holder” or “Asher”). Under the terms of the Note Agreement, the Company will issue to
Asher convertible notes (the “Notes”) of $22,500. The Notes have a nine month maturity date from issuance. The
note bears interest at 8%. Any amount of principal or interest on these notes which is not paid when due shall bear interest
at 22% from the due date until paid. The conversion price shall equal the variable conversion price which shall mean 55%
multiplied by the market price (representing a discount rate of 45%). Market price means the average of the lowest three
trading prices for the common stock during the ten trading day period ending on the latest complete trading day prior to the
conversion date. BCF is contingent on the Company’s average stock price as determined by the conversion formula. This
BCF is not recorded and will be recorded when the contingency is resolved.



F-13







ITEM 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS



Forward-Looking Statements



THIS QUARTERLY REPORT ON
FORM 10-Q, INCLUDING THE FOLLOWING MANAGEMENT'S DISCUSSION AND ANALYSIS, AND OTHER REPORTS FILED BY THE REGISTRANT FROM TIME
TO TIME WITH THE SECURITIES AND EXCHANGE COMMISSION (COLLECTIVELY THE "FILINGS"), CONTAIN FORWARD-LOOKING
STATEMENTS WHICH ARE INTENDED TO CONVEY OUR EXPECTATIONS OR PREDICTIONS REGARDING THE OCCURRENCE OF POSSIBLE FUTURE EVENTS OR
THE EXISTENCE OF TRENDS AND FACTORS THAT MAY IMPACT OUR FUTURE PLANS AND OPERATING RESULTS. THESE FORWARD-LOOKING STATEMENTS
ARE DERIVED, IN PART, FROM VARIOUS ASSUMPTIONS AND ANALYSIS WE HAVE MADE IN THE CONTEXT OF OUR CURRENT BUSINESS PLAN AND
INFORMATION CURRENTLY AVAILABLE TO US AND IN LIGHT OF OUR EXPERIENCE AND PERCEPTIONS OF HISTORICAL TRENDS, CURRENT CONDITIONS
AND EXPECTED FUTURE DEVELOPMENTS AND OTHER FACTORS WE BELIEVE TO BE APPROPRIATE IN THE CIRCUMSTANCES. YOU CAN GENERALLY
IDENTIFY FORWARD-LOOKING STATEMENTS THROUGH WORDS AND PHRASES SUCH AS "SEEK", "ANTICIPATE",
"BELIEVE", "ESTIMATE", "EXPECT", "INTEND", "PLAN", "BUDGET",
"PROJECT", "MAY BE", "MAY CONTINUE", "MAY LIKELY RESULT", AND SIMILAR EXPRESSIONS.
WHEN READING ANY FORWARD-LOOKING STATEMENT YOU SHOULD REMAIN MINDFUL THAT ALL FORWARD-LOOKING STATEMENTS ARE
INHERENTLY UNCERTAIN AS THEY ARE BASED ON CURRENT EXPECTATIONS AND ASSUMPTIONS CONCERNING FUTURE EVENTS OR FUTURE PERFORMANCE
OF OUR COMPANY, AND ARE SUBJECT TO RISKS, UNCERTAINTIES, ASSUMPTIONS AND OTHER FACTORS RELATING TO OUR INDUSTRY AND RESULTS
OF OPERATIONS.



EACH FORWARD-LOOKING STATEMENT SHOULD BE
READ IN CONTEXT WITH, AND WITH AN UNDERSTANDING OF, THE VARIOUS OTHER DISCLOSURES CONCERNING OUR COMPANY AND OUR BUSINESS MADE
IN OUR FILINGS. YOU SHOULD NOT PLACE UNDUE RELIANCE ON ANY FORWARD-LOOKING STATEMENT AS A PREDICTION OF ACTUAL RESULTS OR DEVELOPMENTS.
WE ARE NOT OBLIGATED TO UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENT CONTAINED IN THIS REPORT TO REFLECT NEW EVENTS OR CIRCUMSTANCES
UNLESS AND TO THE EXTENT REQUIRED BY APPLICABLE LAW.



Overview



On November 1, 2010, the Company's Board of
Directors (“BOD”) and management decided to change the focus of its business from entertainment and website development
to websites dedicated to the facilitation of medical tourism. The Company believes that due to the potential high growth in
the medical tourism industry (“MTI”), it is a better use of the Company's resources. The Company discontinued operations
and maintenance of web destinations it launched in the last several years, as it has transitioned operations toward the development
of one or more medical tourism websites.



On April 20, 2011,
the Company launched its initial medical tourism website calledwww.globalhealthvoyager.com.
The website is designed to be an information portal for users to facilitate medical procedures, hospitals, and clinics overseas.
The website is updated regularly and will continue to be enhanced over time.



On August 10, 2011, NT Media Corp. of California,
Inc. changed its name to Global Health Voyager, Inc. (the "Company"). The Company is a Delaware corporation incorporated
on March 14, 2000.



In
2011, the Company discontinued developing media and entertainment assets and channels and phased out its websiteswww.neurotrash.tv,www.singlefathernetwork.com,
andwww.stemcellstalk.com as it shifted its focus to its recently launched medical tourism
web portal.



New Company Focus



The Company redirected its focus to the MTI
which it believes has high growth potential with minimal upfront web portal development costs. The Company recognized a unique
opportunity to utilize its core competencies in web development in the emerging medical tourism market. The Company’s new
vision is to be a premier international MTI via acquisitions, partnerships, affiliations, and the development of web portals for
resources in the MTI. The Company’s mission is to facilitate exceptional health care and services by highly qualified surgeons/physicians
and advanced state-of-the-art facilities abroad for a fraction of the cost of traditional healthcare in the US. The Company extends
its services to other developed nations by providing potential patients the opportunity to research and connect with medical providers
outside of their country of residence. The Company’s sole employee is its president and he will continue his role as such.
The Company plans to hire outside consultants and contractors in the initial phases of the business transition to develop the Company's
websites, partnerships and content with respect to all aspects of non-US medical services, transportation and regulations. The
Company will seek financing for the venture through private placements of equity and the issuance of debt securities to private
investors. There can be no assurance the Company will successfully transition its business operations, attract or retain new personnel
or obtain financing on terms satisfactory to the Company, if at all.



3







The Company’s core competencies in web
developing, marketing, and social networking allow it to cost effectively provide information about world-class healthcare services
via its medical tourism website which was launched in the second quarter of 2011.



The Company intends to capitalize on the growth
in this industry through the development of our own internal platform and through the development of relationships with hospitals
and health care providers worldwide. In considering servicing clients from Canada and Western Europe, another significant
factor driving medical tourism outside of cost savings is timeline for delivery of care.



Currently, there are many small medical tourism
companies that serve particular markets and specialize in certain types of procedures. We believe the medical tourism facilitator
market is ripe for consolidation. There are few, if any, companies that have the depth and reach into all of the different geographies
and medical specializations available to potential patients. Researching countries, facilities and individual doctors is an important
part of the decision process for most patients. Currently, patients must research several different sources to compare pricing,
procedures and providers. A company that can deliver information across all geographies and facilitate introductions to hospitals,
doctors and health care staff involved in every type of procedure could rapidly become the market share leader.



Our goal is to develop our own platform and
to acquire and partner with the leaders in the medical tourism industry, including electronic record management, and grow
the business significantly long into the foreseeable future.



In addition, as part of its
strategy of growth in the MTI, effective October 6, 2011, the Company entered into an Asset Purchase Agreement (the
"Agreement") with Healthcare International Networks, LLC (“HIN”), a privately-owned Delaware limited
liability company ("Seller"). Pursuant to the terms of the Agreement, the Company purchased substantially all of
the operating assets associated with the website "Planet Hospital" as owned and operated by the Seller. The Seller
agreed to retain all of its liabilities whether related to the Planet Hospital website or any other assets acquired by
Company under the Agreement. The Company assumed no liabilities under the Agreement. As consideration for the transfer and
sale of the Planet Hospital assets to the Company, the Company agreed to issue $90,000 of its unregistered Common Stock, at
$0.144 per share (the "Consideration Shares"). The price per share of the Consideration Shares was based upon the
average of the closing price of the Company's Common Stock for the 30 days preceding October 6, 2011. As such 625,000 shares
of Common Stock were to be issued as Consideration Shares. The Consideration Shares have not been issued as the Seller did
not respond to the Company’s repeated requests to provide the names of the individuals to which the shares were to be
issued. The Company is currently involved in a lawsuit with the Seller. The Company has not assumed title to the
Planet Hospital assets including the rights to the name and website domain.



On January 5, 2012, HIN, DBA
Planet Hospital, RupakAcharyya aka Rudy Rupak, and Geoff Moss filed a lawsuit, collectively as "Plaintiffs"
against the Company.  The lawsuit filed by Plaintiffs alleges and seeks damages in the form of monetary relief for: 1)
breach of contract; 2) conversion; and 3) Labor Code violations for failure to pay wages timely; and seeks equitable remedies
in the form of: 1) rescission of contract; 2) declaratory relief; and 3) injunctive relief.



The
Company responded to this lawsuit by way of both a General and Special Demurrer, asserting the Complaint filed by Plaintiffs
must be dismissed as the Plaintiff corporation is not in good standing in its state of incorporation, Delaware, and therefore
does not have the right to pursue legal remedies.  Further, the Company asserts that Plaintiffs' Complaint fails to
state facts sufficient to constitute any cause of action against the Company.  The Company also filed a Request for
Judicial Notice of Plaintiff LLC's corporate standing. The scheduled hearing date for the Company's objection to the lawsuit
was May 16, 2012. On April 20, 2012, Plaintiff filed a First Amended Complaint, correcting the issues raised by the
Defendant's motion.  On May 4, 2012, prior to the hearing on our motions, opposing counsel and our counsel attended a
Case Management Conference and the court took our motion off calendar because the irregularities raised by our motion had not
been addressed.  Thus, the May 16, 2012 motion hearing did not take place.  The Court then set dates and deadlines
for our case. The Court set our trial date for April 2, 2013.  The Final Status Conference is scheduled for March 27,
2013.  The mediation completion date is November 13, 2012 and the Post Mediation Status Conference is November 15, 2012.
 We have been ordered to complete private panel mediation whereby the parties will split the fees.



While the Company
will defend this action, there can be no assurance that we will prevail in the lawsuit. At this time, the Company cannot determine
the amount of damages, if any, it could be responsible for if it does not prevail in the lawsuit. If
the Company were to lose the lawsuit, we could be liable for damages of more than $90,000 and would be responsible for paying the
principals of the lawsuit back wages, penalties and interest.



4







Financing



We
have generated no revenue from the sale of our products during the 2012 fiscal year, therefore, we must continue to rely
on funding from other sources to support our operations. We have no committed sources of financing other than as
disclosed in this Form 10-Q. Sales of our debt and equity securities and loans from related parties have provided us with the
funding we needed in the past, although there is no guaranty that this funding will be available in the future. As we
discuss below, our financial statements have been prepared assuming that we will continue as a going concern. Through June
30, 2012, we incurred cumulative losses of $10,138,601including a net loss for
the six months ended June 30, 2012 of $326,372. It is unknown when, if ever, we will achieve a level of revenues adequate to
support our costs and expenses, including the repayment of debt.



Obtaining outside financing will continue to
be necessary to meet the Company’s anticipated working capital needs for the foreseeable future. Given the Company’s
current financial position, for the immediate future, we expect to operate the Company’s current lines of business under
strict budgetary constraints in order to keep operating expenses as low as possible. We will attempt to negotiate extensions of
the Company’s debt obligations or negotiate for the conversion of some or all of the Company’s debt into equity; however,
there can be no assurance that we will be successful.



In the six months ended June 30, 2012, the
Company issued notes for $36,100 with interest of 12%, $25,000 with interest of 5% and $50,000 with monthly interest of $500. See
the consolidated financial statements of the Company in Part I Item1 for further details on these financing transactions.



Results of Operations



Three Months Ended June 30, 2012 Compared
to Three Months Ended June 30, 2011



Revenues for the three months ended June
30, 2012 and 2011 were $0.



The Company’s
total operating expenses were $99,475 during the three months ended June 30, 2012, a decrease of $30,714 or 24%, as compared to
$130,189 for the three months ended June 30, 2011. General and administrative expenses were $99,475 during the three months
ended June 30, 2012, a decrease of $30,714 or 24%, as compared to $130,189 for the three months ended June 30, 2011.  The
Company also incurred interest costs related to various notes in the amount of $59,803, an increase of $8,763 from the prior period
when we reported interest costs of $51,040. Operations were limited by the lack of available cash.



Six Months Ended June 30, 2012 Compared
to Six Months Ended June 30, 2011



Revenues for the six months ended June
30, 2012 and 2011 were $0.



The
Company’s total operating expenses were $207,943 during the six months ended June 30, 2012, a decrease of $17,575
or 8%, as compared to $225,518 for the six months ended June 30, 2011. General and administrative expenses were
$207,943 during the six months ended June 30, 2012, a decrease of $17,575 or 8%, as compared to $225,518 for the six months
ended June 30, 2011.  The Company also incurred interest costs related to various notes in the amount of $119,059; an
increase of $21,087 from the prior period when we reported interest costs of $97,972. Operations were limited by the
lack of available cash.



Off-Balance Sheet Arrangements



We have not entered into any off-balance sheet
arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial
condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources, and that would be
considered material to investors.



Liquidity and Capital Resources



We have incurred
operating losses since inception. As ofJune 30, 2012, we have an accumulated deficit of $10,138,601. AtJune 30, 2012, we have $2,000 in cash and equivalents and a net working capital deficit of $5,205,406.



The
Company had cash of $2,000 at June 30, 2012. Historically the Company’s source of cash for operations has been the sale
of equity and debt securities. There can be no assurance that sales of the Company’s securities, or sale of the
Company’s products and services will provide sufficient capital for its operations or that the Company will not
encounter unforeseen difficulties that may deplete its capital resources more rapidly than anticipated. As of June 30, 2012,
approximately $695,240 in principal and interest of certain promissory notes issued by the Company were due or will be coming
due on or before July 20, 2012, which is the latest maturity date of its existing notes.  The notes due on or before
July 20, 2012 were verbally extended and are payable upon demand.



The
Company and its wholly owned subsidiary, eCast Media Corporation, Inc. (“eCast”), were dependent on borrowed
or invested funds to finance their ongoing operations. As ofJune 30, 2012, eCast
owed $620,000 on 6% convertible notes and the Company owed $210,338 on 6% convertible notes. These notes were issued to two
of the Company’s major stockholders. These notes are classified as current liabilities. We anticipate we will
continue borrowing funds or obtaining additional equity financing to provide working capital. We do not have sufficient cash
on hand or from operations to support the Company's operations for the next 12 months.



5







The audit report of the Company’s independent
registered public accounting firm for the year ended December 31, 2011, included in the Company’s Annual Report on Form 10-K
for the year then ended, includes a “going concern” explanation. In the auditor’s opinion, the Company’s
limited operating history and accumulated deficit as of December 31, 2011, raised substantial doubt about the Company’s ability
to continue as a going concern. We require approximately $5.21 million over the next 12 months to pay off accounts payable, accrued
expenses and the convertible notes and notes payable reaching maturity unless we obtain additional extensions.



Due to our limited cash flow, operating losses
and intangible assets, it is unlikely we could obtain financing through commercial or banking sources. Consequently, we are dependent
on continuous cash infusions from our major stockholders and other outside sources to fund our current operations. If these outside
sources are unwilling or unable to provide necessary working capital to us, we will probably not be able to sustain operations.
We have no written agreements or contractual obligations in place which require our outside sources to continue to finance our
operations. The Company's and eCast's convertible notes of $1,222,430 are convertible when the Company's or eCast's securities (as
the case may be) are trading publicly and the underlying stock of the convertible notes has been registered with the SEC on a registration
statement that has been declared effective. If they remain unpaid, the notes will automatically convert to Common Stock on the
fifth anniversary of their respective issuances. Thus, $867,838 of current convertible notes would be mandatorily converted
during 2012 unless they become eligible for conversion prior to that time, or have been extended by the parties. The parties have
verbally agreed to extend the mandatory conversion for one year.



If adequate funds do not become available,
management believes its officers and directors will contribute capital amounts necessary to fund the Company’s ongoing expenses;
however, the Company’s officers and directors are under no obligation to do so. If we are unable to pay the Company’s
debt as it becomes due and are unable to obtain financing on terms acceptable to us, or at all, we will not be able to accomplish
any or all of the Company’s initiatives and will be forced to consider steps that would protect the Company’s assets
against creditors.



Operating Activities



During the six months
ended June 30, 2012, the Company used $125,031 of cash in operating activities, primarily to fund its net loss. Non-cash adjustments
included $2,686 for the amortization of interest on warrants, $22,988 for share-based payments to consultants, and $630 for a gain
on settlement of debt. Cash provided by operating activities included $183,241 in accrued expenses. Cash used in operating activities
included $6,945 in accounts payable.



During the six months
ended June 30, 2011, the Company used $110,072 of cash in operating activities. Non-cash adjustments included $13,500 for share-based
payments to consultants and employees. Cash provided by operating activities included $33,217 in accounts payable and $173,772 in
accrued expenses. Cash used in operating activities included $6,271 in other current assets.



Critical Accounting Policies



We have no critical accounting policies that
by the nature of the estimates or assumptions are material due to the levels of subjectivity and judgment necessary to account
for highly uncertain matters or the susceptibility of such matters to change.



Material Trends, Events or Uncertainties



The Company is not
certain how the current economic downturn may affect its business. Because of the global recession, government agencies and
private industry may not have the funds to purchase global medical tourism and healthcare services. It may also be more difficult
for the Company to raise capital in the current economic environment. Other than as discussed herein, the Company does not know
of any material trends, events or uncertainties that may impact its operations in the future.



Going Concern



The accompanying financial
statements were prepared assuming the Company will continue as a going concern. This basis of accounting contemplates the recovery
of the Company’s assets and the satisfaction of its liabilities in the normal course of business. Through June 30, 2012,
the Company has incurred cumulative losses of $10,138,601 including a net loss for the six months ended June 30, 2012 of $326,372.
As the Company has no cash flow from operations, its ability to maintain its status as an operating company is dependent
upon obtaining adequate cash to finance its overhead, sales and marketing activities, and the acquisition of other companies in
the MTI industry. It is unknown when, if ever, the Company will achieve a level of revenues adequate to support its costs and expenses.
In order for the Company to meet its basic financial obligations, including rent, salaries, debt service and operations, it plans
to seek additional equity or debt financing. Because of the Company’s history and current debt levels, there is considerable
doubt the Company will be able to obtain financing. The Company’s ability to meet its cash requirements for the next 12 months
depends on its ability to obtain such financing. Even if financing is obtained, any such financing will likely involve additional
fees and debt service requirements which may significantly reduce the amount of cash the Company will have for its operations.
Accordingly, there is no assurance the Company will be able to implement its plans.



6







The Company expects
to continue to incur substantial operating losses for the foreseeable future, and it cannot predict the extent of the future losses
or when it may become profitable, if ever. The Company expects to incur increasing sales and marketing, general and administrative
expenses. Also, the Company has a substantial amount of short-term debt, which will need to be repaid
or refinanced, unless it is converted into equity. As a result, if the Company begins to generate revenues from operations, those
revenues will need to be significant in order to cover current and anticipated expenses. These factors raise substantial doubt
about the Company's ability to continue as a going concern unless it is able to obtain substantial additional financing in the
short term and generate revenues over the long term. If the Company is unable to obtain financing, it would likely discontinue
its operations.



Pending
Restatement To 2011 Financial Statements



The Company,
together with the Company’s independent registered public accounting firm, has discovered an error in the Company’s
audited financial statements for the year ended December 31, 2011. Specifically, the financial statements as of December 31, 2011
were restated to correct amortization of consulting services of $212,500 which were substantially completed in the fourth quarter
of 2011. See Note 11 to the Notes to Consolidated Financial Statements, June 30, 2012 and June 30, 2011 (Unaudited) and December
31, 2011 (Restated), attached to this Quarterly Report, until the restated financial statements for the fiscal year ended December
31, 2011 are filed by the Company, the financial statement filed with the Securities and Exchange Commission prior to this Quarterly
Report should not be relied upon.





ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT
MARKET RISK



As a Smaller Reporting Company, the Company is not required to respond
to this Item 3.



ITEM 4.  CONTROLS AND PROCEDURES



Evaluation of Disclosure Controls and Procedures



The term “disclosure controls and procedures”
means controls and other procedures of the Company designed to ensure that information required to be disclosed by the Company
in the reports that it files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded,
processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and
procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by
the Company in the reports that it files or submits under the Act is accumulated and communicated to the Company’s management,
including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to
allow timely decisions regarding required disclosure.



Under the supervision and with the participation
of our management, including our Chief Executive Officer and Acting Chief Financial Officer (the "Certifying Officer"),
we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e)
and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our Certifying
Officer concluded that our disclosure controls and procedures were not effective such that the information required to be disclosed
by us in reports filed under the Exchange Act is (a) recorded, processed, summarized and reported within the time periods specified
in the SEC's rules and forms and (b) accumulated and communicated to our management, including our Chief Executive Officer, as
appropriate to allow timely decisions regarding disclosure.



Changes In Internal Control Over Financial Reporting



There were no changes in our internal control
over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30,
2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.



Additional Disclosure Concerning Controls and Procedures



We currently believe the Company has material
weaknesses in its disclosure controls and procedures. We will continue to work in the coming months to address such weaknesses.
We believe that the out-of-pocket costs, the diversion of management's attention from running the day-to-day operations and operational
changes caused by the need to make changes in our internal control and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under
the Exchange Act) could be significant and still we may not achieve significant improvements in our internal controls and procedures.
If the time and costs associated with such compliance exceed our current expectations, our results of operations and the accuracy
and timeliness of the filing of our annual and periodic reports may be materially adversely affected and could cause investors
to lose confidence in our reported financial information, which could have a negative effect on the trading price of our Common
Stock.



7







PART II

OTHER INFORMATION



ITEM 1. LEGAL PROCEEDINGS



During 2002, the Company's subsidiary settled
a lawsuit with its prior landlord for $100,000. As of June 30, 2012 the balance of the settlement had not been paid and is reflected
as a current liability in the accompanying consolidated balance sheet. Management is aware of a threatened litigation matter involving
the nonpayment of certain legal fees of approximately $9,000. Management is not aware of any attempts by the claimant for pursuit
of the litigation.



On November 1, 2010 the accounting firm of
A.J. Robbins, P.C. filed a lawsuit in the District Court, City and County of Denver, Colorado, seeking recovery of fees allegedly
owed for accounting services performed during 2004 to 2008. The claims have been asserted against the Company, a second corporate
defendant, and our CEO, as a result of a personal guarantee. On December 15, 2010, Defendants filed an Answer which asserted several
defenses. The parties exchanged initial disclosures, and the matter was set for trial commencing on December 5, 2011. On August
3, 2011 the parties entered into a settlement agreement whereby the Defendants in the case will jointly pay $85,000 to the plaintiffs.
The Company was responsible to pay 50% of the cash payments, the other 50% of which was the responsibility of a second defendant.
The cash payments were scheduled to be made in equal monthly payments over 7 months commencing on August 31, 2011. In consideration
of the settlement, the parties have executed a mutual release and have agreed to withdraw the lawsuit. The releases and withdrawal
are contingent upon the Company's full performance of the settlement agreement terms. As of August 16, 2012, out of the cash payments
that the Company was responsible for under the settlement agreement, $8,520.82 is still owed and unpaid. This balance due is for
part of the February 28, 2012 payment. Plaintiff has the right to get a judgment for $175,000 minus the payments that were made,
if we fail to perform under the terms of the settlement agreement and if they serve us with a notice of default, which they have
not.



On January 5, 2012, Healthcare International
Network, LLC, a Delaware limited liability company, DBA Planet Hospital, RupakAcharyya aka Rudy Rupak, and Geoff Moss filed a lawsuit
at the Los Angeles Superior Court, Case No. BC476301 collectively as "Plaintiffs" against the Company.  The lawsuit
filed by Plaintiffs alleges and seeks damages in the form of monetary relief for: 1) breach of contract; 2) conversion; and 3)
Labor Code violations for failure to pay wages timely; and seeks equitable remedies in the form of: 1) rescission of contract;
2) declaratory relief; and 3) injunctive relief.



The Company responded
to this lawsuit by way of both a General and Special Demurrer, asserting the Complaint filed by Plaintiffs must be dismissed as
the Plaintiff corporation is not in good standing in its state of incorporation, Delaware, and therefore does not have the right
to pursue legal remedies.  Further, the Company asserts that Plaintiffs' Complaint fails to state facts sufficient to constitute
any cause of action against the Company.  The Company also filed a Request for Judicial Notice of Plaintiff LLC's corporate
standing. The scheduled hearing date for the Company's objection to the lawsuit was May 16, 2012. On April 20, 2012, Plaintiff
filed a First Amended Complaint, correcting the issues raised by the Defendant's motion.  On May 4, 2012, prior to the hearing
on our motions, opposing counsel and our counsel attended a Case Management Conference and the court took our motion off calendar
because the irregularities raised by our motion had not been addressed.  Thus, the May 16, 2012 motion hearing did not take
place.  The Court then set dates and deadlines for our case.The Court set our trial date for April 2, 2013.  The Final
Status Conference is scheduled for March 27, 2013.  The mediation completion date is November 13, 2012 and the Post Mediation
Status Conference is November 15, 2012.  We have been ordered to complete private panel mediation whereby the parties will
split the fees.



While the Company
will defend this action, there can be no assurance that we will prevail in the lawsuit. At this time, the Company cannot determine
the amount of damages, if any, it could be responsible for if it does not prevail in the lawsuit. If
the Company were to lose the lawsuit, we could be liable for damages of more than $90,000 and would be responsible for paying the
principals of the lawsuit back wages, penalties and interest.



ITEM 1A. RISK FACTORS



As a Smaller Reporting Company, the Company is not required to respond
to Item 1A.



ITEM 2. UNREGISTERED SALES OF EQUITY
SECURITIES



During the period covered by this Report, the
Company issued and sold the following unregistered securities. The Company did not employ any form of general solicitation or advertising
in connection with the offer and sale of the securities. In addition, the Company believes the investors are all “accredited
investors” as defined in Rule 501(a) of the Securities Act of 1933, as amended (the "Securities Act"). For these
reasons, among others, the offer and sale of the securities were made in reliance on the exemption from registration provided by
Section 4(2) of the Securities Act or Regulation D promulgated by the Securities and Exchange Commission (the “SEC”)
under the Securities Act. The proceeds of the sale of the securities will be used by the Company for general working capital purposes.



8







On April 4, 2012, the Company
issued to Asher Enterprises, Inc. convertible notes in the principal amount of $37,500 at interest 8% and due on January 9,
2013 in exchange for cash in the amount of $37,500.



On April 27, 2012, the Company issued to Jupiter
Investments and Orbinvest Capital, LLC convertible notes in the principal amount of $5,000 and $10,000, respectively, at interest
12% and due on April 27, 2015 in exchange for cash in the amount of $5,000 and $10,000, respectively.



On May 14, 2012, the Company
issued 2,027,631 shares of the Company’s Common Stock to a note holder upon the conversion, at a conversion price of
$0.0038 per share, of $7,705 in accrued interest on a convertible promissory note.



ITEM 3. DEFAULTS UPON SENIOR SECURITIES



None.



ITEM 4.  MINE SAFETY DISCLOSURES



The Company has no disclosure applicable to this item.



ITEM 5.  OTHER INFORMATION



On June 24, 2012 the Company
entered into a Memorandum of Understanding (“MOU”) with Janus Medical Systems of Singapore. This MOU grants the Company exclusive global rights to market, sell and distribute Atreya, a dynamic personal health record management
system, to be used by consumers for medical record organization and information distribution to their personal physicians.
The Atreya product has a multitude of features and functions, including the storage of medical documents, x-rays, previous
procedures, prescription information, calendar of dosage, appointments and other vital information. The Atreya product is Health
Insurance Privacy and Portability Actcompliant, and employs features that allow physicians permissions to see
prior health history, without compromising the data integrity and compliance.



ITEM 6. EXHIBITS



Exhibits:



|Exhibit 3.1  | (1) | Certificate of Incorporation, as amended                                                                              
|------------ | --- | ----------------------------------------------------------------------------------------------------------------------
|Exhibit 3.2  | (2) | Bylaws dated March 14, 2000.                                                                                          
|Exhibit 4.1  | (3) | 2009 Equity Incentive Plan dated March 6, 2009                                                                        
|Exhibit 4.2  | (4) | Form of Common Stock Purchase Warrant                                                                                 
|Exhibit 10.1 | *   | Janus Medical Systems MOU                                                                                             
|Exhibit 31.1 | *   | Certification pursuant to Section 302 of the Sarbanes-Oxley Act
        of 2002                                       
|Exhibit 32.1 | *   | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



* Filed herewith.

|(1) |  | Filed as an exhibit to the Company’s Quarterly Report on Form 10-Q filed on
August 15, 2011.
|--- |  | --------------------------------------------------------------------------------------------

|(2) |  | Filed as an exhibit to the Company’s Registration Statement (File No. 333-38322),
Amendment No. 1, on Form SB-2/A on August 23, 2000.
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------

|(3) |  | Filed as an exhibit to the Company’s Registration Statement (File No. 333-157748)
on Form S-8 filed on March 6, 2009.
|--- |  | ---------------------------------------------------------------------------------------------------------------------

|(4) |  | Filed as an exhibit to the Company’s Current Report on Form 8-K filed on August
3, 2011.
|--- |  | ----------------------------------------------------------------------------------------



9







SIGNATURES



Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



|                       | GLOBAL HEALTH VOYAGER, INC.
|---------------------- | ---------------------------
|                       |                            
|Dated: August 20, 2012 |                            
|                       |                            
|                       |                            



10